Schechter Adam H — SEC Form 4 filings
SEC reporting owner CIK 1376841. 29 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2024-02-06 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 54,353 shares, $14,472,294 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: sale of 8,705 shares @ $279.96 ($2,437,047) in LABCORP HOLDINGS INC., filed 2026-03-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | President & CEO, Director | 18 | — | 9 legs · 54,353 sh · $14,472,294 | 40 |
| DAVITA INC. (DVA) | Director | 11 | — | — | 11 |
Form 4 filings — Schechter Adam H
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | DAVITA INC. (DVA) | Grant/award (A): 278 @ $0 | EDGAR |
| 2026-08-12 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 4,669 @ $320.37 | EDGAR |
| 2026-05-18 | 4 | DAVITA INC. (DVA) | Grant/award (A): 250 @ $0 | EDGAR |
| 2026-05-13 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 5,903 @ $254.50 | EDGAR |
| 2026-03-30 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 58,470 @ $0 · Tax withholding (F): 26,106 @ $268.38 | EDGAR |
| 2026-03-17 | 4 | DAVITA INC. (DVA) | Grant/award (A): 332 @ $0 | EDGAR |
| 2026-03-05 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 8,705 @ $279.96 | EDGAR |
| 2026-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 5,273 @ $284.38 · Option exercise (M): 3,656 · Tax withholding (F): 1,521 @ $289.89 · Option exercise (M): 3,656 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 31,700 (derivative) @ $0 · Grant/award (A): 10,440 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 4,460 · Tax withholding (F): 1,315 @ $277.20 · Option exercise (M): 3,249 · Tax withholding (F): 1,352 @ $274.01 · Option exercise (M): 4,460 (derivative) @ $0 · Option exercise (M): 3,249 (derivative) @ $0 | EDGAR |
| 2025-11-17 | 4 | DAVITA INC. (DVA) | Grant/award (A): 411 @ $0 | EDGAR |
| 2025-11-13 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 5,745 @ $262.75 | EDGAR |
| 2025-08-19 | 4 | DAVITA INC. (DVA) | Grant/award (A): 369 @ $0 | EDGAR |
| 2025-08-13 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 5,643 @ $266.78 | EDGAR |
| 2025-05-16 | 4 | DAVITA INC. (DVA) | Grant/award (A): 348 @ $0 | EDGAR |
| 2025-05-13 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 6,105 @ $248.73 | EDGAR |
| 2025-03-31 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 30,469 @ $0 · Tax withholding (F): 13,584 @ $231.67 | EDGAR |
| 2025-03-18 | 4 | DAVITA INC. (DVA) | Grant/award (A): 349 @ $0 | EDGAR |
| 2025-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 6,121 @ $244.62 · Option exercise (M): 2,963 · Tax withholding (F): 1,226 @ $245.14 · Grant/award (A): 33,100 (derivative) @ $0 · Grant/award (A): 10,970 (derivative) @ $0 · Option exercise (M): 2,963 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 4,460 · Tax withholding (F): 1,240 @ $247.74 · Option exercise (M): 3,250 · Tax withholding (F): 1,345 @ $246.27 · Option exercise (M): 4,460 (derivative) @ $0 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | DAVITA INC. (DVA) | Grant/award (A): 312 @ $0 | EDGAR |
| 2024-11-13 | 4 | LABCORP HOLDINGS INC. (LH) | Sale (S): 6,189 @ $243.47 | EDGAR |
| 2024-08-19 | 4 | DAVITA INC. (DVA) | Grant/award (A): 333 @ $0 | EDGAR |
| 2024-05-17 | 4 | DAVITA INC. (DVA) | Grant/award (A): 363 @ $0 | EDGAR |
| 2024-03-29 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 72,435 · Tax withholding (F): 31,799 @ $216.57 · Option exercise (M): 72,435 (derivative) | EDGAR |
| 2024-03-19 | 4 | DAVITA INC. (DVA) | Grant/award (A): 366 @ $0 | EDGAR |
| 2024-02-13 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 2,964 · Tax withholding (F): 1,231 @ $227.45 · Option exercise (M): 2,964 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 3,250 · Tax withholding (F): 1,149 @ $223.71 · Grant/award (A): 13,380 (derivative) @ $0 · Grant/award (A): 41,400 (derivative) @ $0 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 3,094 · Tax withholding (F): 822 @ $221.54 · Option exercise (M): 3,094 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376841 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →